News

There's expectations weight-loss drug Wegovy will eventually be funded publicly, according to experts. It's become available ...
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...
Nearly 90 percent of Dutch citizens believe that obesity medication should be covered by the basic health insurance package, ...
A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others.
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is unfunded and could cost users around $500 a month.
These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...
Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...
UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...